Yunnan Jianzhijia Health-Chain Co., Ltd. (SHSE:605266) agreed to acquire a 80% stake in Hebei Tangren Pharmacy Co.,Ltd. from Zhejiang Free Trade Zone Juejing Zhiyuan Enterprise Management Partnership, Zhejiang Free Trade Zone Mingzhao Yuanzhi Enterprise Management Partnership and Zhejiang Free Trade Zone Jucheng Qinhui Enterprise Management Partnership for CNY 1.7 billion on June 29, 2022. Yunnan Jianzhijia Health-Chain Co., Ltd. board approved the transaction. As of December 31, 2021, Hebei Tangren Pharmacy Co.,Ltd. reported total assets of CNY 1,077.27 million, total common equity of CNY 513.67 million, EBIT of CNY 117.38 million and total income of CNY 85.51 million. The transaction is subject to regulatory approval. As of August 13, 2022 regulatory board approved the deal. Beijing Deheng (Shenzhen) Law Firm acted as legal advisor to Yunnan Jianzhijia Health-Chain Co., Ltd. and Hongta Securities Co., Ltd. acted as financial advisor to Yunnan Jianzhijia Health-Chain Co., Ltd.